ADIPOQ and chronic kidney disease: In observational studies in CKD patients, high circulating adiponectin levels are associated with higher mortality [70,71] while lower or higher adiponectin levels associated to increased mortality and cardiovascular events in dialysis patients [72,73,74,75].